who invented glp 1 drugs Her work paved the way for blockbuster obesity drugs. Now, she's fighting for recognition | Science Joel Habener, Whose Research Helped

In rats, the drugs, known as glucagon-like-peptide-1 (GLP-1) receptor agonists, have been shown to cause thyroid C-cell tumors

Delayed gastric emptying was first noted in patients with diabetes and subsequently reported by Boas in 1925

Last reviewed: July 8, 2026 Last updated: July 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Disclaimer: This content is for informational purposes only and does not constitute medical advice

Route of Administration 17.7.4

If you are researching GLP-1 related legal developments , understanding the regulatory landscape around these products becomes even more important